Zhong Zheng

High miR-324-5p expression predicts unfavorable prognosis of gastric cancer and facilitates tumor progression in tumor cells

Jun Li, Zhong Zheng, Junyan An, 2021, Diagnostic Pathology.

Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma

Weili Zhao, Wen Wu, Shu Cheng, 2019, Clinical Cancer Research.

Autophagy and Leukemia.

Weili Zhao, Shu Cheng, Li Wang, 2020, Advances in experimental medicine and biology.

Autophagy and Myeloma.

Weili Zhao, Li Wang, Zhong Zheng, 2020, Advances in experimental medicine and biology.

Advances in the multi-omics landscape of follicular lymphoma

Tianyuan Xu, Zhong Zheng, W. Zhao, 2023, International journal of biological sciences.

A novel prognostic model based on four circulating miRNA in diffuse large B‐cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression

Weili Zhao, A. Janin, C. Leboeuf, 2020, Molecular oncology.

Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma

Zhi-xiang Shen, Saijuan Chen, Shu Cheng, 2013, Journal of Hematology & Oncology.